Effect of gefitinib (ZD1839) on metastatic brain tumour

Lung Cancer. 2004 Mar;43(3):371-2. doi: 10.1016/j.lungcan.2003.09.017.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary*
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Middle Aged
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Quinazolines / therapeutic use*
  • Salvage Therapy
  • Treatment Outcome

Substances

  • Enzyme Inhibitors
  • Quinazolines
  • Protein-Tyrosine Kinases
  • Gefitinib